Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics

Int J Pharm. 2021 Sep 5:606:120905. doi: 10.1016/j.ijpharm.2021.120905. Epub 2021 Jul 20.

Abstract

Cancer is one of the most prevalent and deadly diseases in the world, to which conventional treatment options, such as chemotherapy and radiotherapy, have been applied to overcome the disease or used in a palliative manner to enhance the quality of life of the patient. However, there is an urgent need to develop new preventive and treatment strategies to overcome the limitations of the commonly used approaches. The field of cancer nanomedicine, and more recently the field of nanotheranostics, where imaging and therapeutic agents are combined in a single platform, provide new opportunities for the treatment and the diagnosis of cancer. This combination could bring us closer to a more personalized and cared-for therapy, in opposition to the conventional and standardized approaches. Gene therapy is a promising strategy for the treatment of cancer that requires a transport system to efficiently deliver the genetic material into the target cells. Hence, the main purpose of this work was to review recent findings and developments regarding theranostic nanosystems that incorporate both gene therapy and imaging agents for cancer treatment.

Keywords: Cancer; Gene therapy; Medical imaging; Nanoparticles; Theranostic nanosystems.

Publication types

  • Review

MeSH terms

  • Genetic Therapy
  • Humans
  • Nanoparticles*
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / therapy
  • Precision Medicine
  • Quality of Life
  • Theranostic Nanomedicine